You are here

lung cancer

3 Lung Cancer Stocks That Could Soar in September

3 Lung Cancer Stocks That Could Soar in September

Motley Fool

Flag link:

Amgen results beat estimates, lung cancer trial planned

Amgen results beat estimates, lung cancer trial planned

Yahoo/Reuters

clinical trials

Flag link:

AstraZeneca spearheads lung cancer alliance aiming to boost survival rates

AstraZeneca spearheads lung cancer alliance aiming to boost survival rates

Fierce Pharma

Lung Ambition Alliance

Flag link:

Biodesix Looks to Become ‘the’ Lung Cancer Detection Co. With New Acquisition

Biodesix Looks to Become ‘the’ Lung Cancer Detection Co. With New Acquisition

Medical Devices and Diagnostics Industry

Flag link:

Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies

Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies

CP Wire

Exosome Diagnostics

prostate cancer

Flag link:

Spotlight on: Exosome Diagnostics, first to develop RNA-based liquid biopsies

Exosome Diagnostics

prostate cancer

Flag link:

Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?

Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?

Investors Business Daily

Flag link:

Early cancer drug data give Amgen hope it's 'cracked KRAS code'

Early cancer drug data give Amgen hope it's 'cracked KRAS code'

Biopharma Dive

colorectal cancer

pancreatic cancer

Flag link:

For some lung cancer patients, Keytruda provides lasting benefit

For some lung cancer patients, Keytruda provides lasting benefit

Biopharma Dive

Flag link:

Google’s AI improves accuracy of lung cancer diagnosis, study shows

Google’s AI improves accuracy of lung cancer diagnosis, study shows

Stat

artificial intelligence

Flag link:

J&J's quest to detect lung cancer before it emerges

J&J's quest to detect lung cancer before it emerges

Fierce Biotech

Flag link:

AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs

AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs

Fierce Pharma

Flag link:

Spectrum yanks marketing application for Neulasta rival after FDA demands more data

Spectrum yanks marketing application for Neulasta rival after FDA demands more data

Endpoints

Spectrum Pharmaceuticals

Flag link:

Roche gets European approval for Tecentriq combo vs. lung cancer

Roche gets European approval for Tecentriq combo vs. lung cancer

Reuters

metastatic non-squamous non-small cell lung cancer

Flag link:

J&J bags option on AdoRx lung cancer drugs

J&J bags option on AdoRx lung cancer drugs

Fierce Biotech

drug development

Flag link:

Real-World Data on Medtronic's Lung Cancer Device Is Promising

Real-World Data on Medtronic's Lung Cancer Device Is Promising

Medical Devices and Diagnostics Industry

electromagnetic navigation bronchoscopy

Flag link:

A New Collaboration Could Be Key in the Early Detection of Lung Cancer

A New Collaboration Could Be Key in the Early Detection of Lung Cancer

Medical Devices and Diagnostics Industry

Flag link:

OncoCyte's lung cancer liquid biopsy test shows 90% sensitivity

OncoCyte's lung cancer liquid biopsy test shows 90% sensitivity

BioCentury

Flag link:

Veracyte Finds Ally in J&J for Early Lung Cancer Detection

Veracyte Finds Ally in J&J for Early Lung Cancer Detection

Medical Devices and Diagnostics Industry

genomic diagnostics

Flag link:

New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

BioSpace

Bristol-Myers Squibb

Flag link:

Pages